Doctors and scientists who spoke to HuffPost are worried for a multitude of reasons and want you to know that this will ...

Prof. Benjamin Aribisala, the Director of Lagos State University Centre of Excellence for Sargassum Research, writes from ...

Scientists say HHS’s decision to stop investing in mRNA vaccine research is another sign of the growing politicization of ...

The deal will involve Novatech Research and Development JSC, a Vietnam-incorporated entity, being carved out of VinFast ...

On Aug. 5, Robert F. Kennedy Jr. posted video to X announcing HHS was canceling mRNA vaccine research, confusing the Trump ...

The deal would be the latest cash injection by billionaire Pham Nhat Vuong to make loss-making VinFast a viable player in the ...

Net loss (GAAP) narrowed to $6.1 million in Q2 2025, a 22.8% improvement from the prior-year period, driven by reduced research and development spending. No product revenue reported; The company’s ...

HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.

They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, ...

Can Boston stay on top in biotech? Find out on Sept 17, 6-9 p.m. EDT to explore talent shifts, funding, and Boston’s future.

The Blast Overpressure Tool, developed to minimize exposure to shock waves generated by heavy weapon fire, now incorporates ...